<--- Back to Details
First PageDocument Content
Health / Pharmaceutical sciences / Pharmaceutical industry / Food and Drug Administration / Advertising / Direct-to-consumer advertising / Unnecessary health care / Prescription Drug User Fee Act / Criticism of the Food and Drug Administration
Date: 2008-05-08 13:43:30
Health
Pharmaceutical sciences
Pharmaceutical industry
Food and Drug Administration
Advertising
Direct-to-consumer advertising
Unnecessary health care
Prescription Drug User Fee Act
Criticism of the Food and Drug Administration

United States Government Accountability Office GAO Testimony Before the Subcommittee on Oversight

Add to Reading List

Source URL: www.gao.gov

Download Document from Source Website

File Size: 265,24 KB

Share Document on Facebook

Similar Documents

Capital Reporting Company Public Meeting on PDUFA VIU.S. FOOD & DRUG ADMINISTRATION PRESCRIPTION DRUG USER FEE ACT

Capital Reporting Company Public Meeting on PDUFA VIU.S. FOOD & DRUG ADMINISTRATION PRESCRIPTION DRUG USER FEE ACT

DocID: 1t0K4 - View Document

Prescription Drug User Fee Act (PDUFA) Reauthorization Public Meeting August 15, 2016 1  Basic PDUFA Construct

Prescription Drug User Fee Act (PDUFA) Reauthorization Public Meeting August 15, 2016 1 Basic PDUFA Construct

DocID: 1sUEh - View Document

Prescription Drug User Fee Act (PDUFA) Reauthorization August 15, 2016  Page 1 1  FOOD AND DRUG ADMINISTRATION (FDA)

Prescription Drug User Fee Act (PDUFA) Reauthorization August 15, 2016 Page 1 1 FOOD AND DRUG ADMINISTRATION (FDA)

DocID: 1sUz3 - View Document

United States Government Accountability Office  GAO Testimony Before the Subcommittee on Oversight

United States Government Accountability Office GAO Testimony Before the Subcommittee on Oversight

DocID: 1rfHg - View Document

Best Practices in Developing Proprietary Names for Drugs

Best Practices in Developing Proprietary Names for Drugs

DocID: 1r8R5 - View Document